NDAORALTABLETPriority Review
Lifecycle
Pre-Launch
Data completeness
0/8 — Limited
Priority Review
Drug data last refreshed 10h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
This is a fixed-dose combination tablet containing lamivudine, zidovudine, and abacavir—three nucleoside reverse transcriptase inhibitors (NRTIs) used to treat HIV-1 infection. The combination leverages synergistic antiviral activity to suppress viral replication and reduce the risk of resistance development. It represents a convenient multi-drug formulation for treatment-naive and treatment-experienced HIV patients.
Pre-Launch
Early-stage portfolio entry with significant ramp potential; commercial team will focus on market education and payer negotiations in a mature HIV treatment segment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
This pre-launch product offers entry-level and mid-career professionals the opportunity to support market launch of a HIV treatment in a competitive, mature segment. Roles will emphasize payer education, physician engagement, and rapid market penetration in a price-sensitive therapeutic area with established generic competition.
Brand ManagerMedical Science Liaison
Worked on LAMIVUDINE; ZIDOVUDINE; ABACAVIR at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.